{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:21:02Z","timestamp":1794043262082,"version":"4.8.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-024-05212-7","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:18:35Z","timestamp":1735561115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9532-2859","authenticated-orcid":false,"given":"Yuki","family":"Kotani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-0565","authenticated-orcid":false,"given":"Alessandro","family":"Belletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bonaccorso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"5212_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMra1208943","volume":"369","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726\u201334.","journal-title":"N Engl J Med"},{"key":"5212_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"5212_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","volume":"24","author":"LW Busse","year":"2020","unstructured":"Busse LW, Barker N, Petersen C. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. Crit Care. 2020;24:36.","journal-title":"Crit Care"},{"key":"5212_CR4","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.accpm.2023.101193","volume":"42","author":"M Leone","year":"2023","unstructured":"Leone M, Einav S, Antonucci E, Depret F, Lakbar I, Martin-Loeches I, et al. Multimodal strategy to counteract vasodilation in septic shock. Anaesth Crit Care Pain Med. 2023;42:101193.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"5212_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","volume":"27","author":"M Ibarra-Estrada","year":"2023","unstructured":"Ibarra-Estrada M, Kattan E, Aguilera-Gonz\u00e1lez P, Sandoval-Plascencia L, Rico-Jauregui U, G\u00f3mez-Partida CA, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023;27:110.","journal-title":"Crit Care"},{"key":"5212_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.09.021","author":"JJ Patel","year":"2022","unstructured":"Patel JJ, Willoughby R, Peterson J, Carver T, Zelten J, Markiewicz A, et al. High-dose intravenous hydroxocobalamin (Vitamin B12) in septic shock: a double-blind, allocation-concealed, placebo-controlled single-center pilot randomized controlled trial (the IV-HOCSS trial). Chest. 2022. https:\/\/doi.org\/10.1016\/j.chest.2022.09.021.","journal-title":"Chest"},{"key":"5212_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","volume":"7","author":"T Auchet","year":"2017","unstructured":"Auchet T, Regnier M-A, Girerd N, Levy B. Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017;7:43.","journal-title":"Ann Intensive Care"},{"key":"5212_CR8","doi-asserted-by":"publisher","first-page":"e0142605","DOI":"10.1371\/journal.pone.0142605","volume":"10","author":"A Belletti","year":"2015","unstructured":"Belletti A, Musu M, Silvetti S, Saleh O, Pasin L, Monaco F, et al. Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS ONE. 2015;10:e0142605.","journal-title":"PLoS ONE"},{"key":"5212_CR9","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","volume":"319","author":"WF McIntyre","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA. 2018;319:1889\u2013900.","journal-title":"JAMA"},{"key":"5212_CR10","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","volume":"45","author":"M Nagendran","year":"2019","unstructured":"Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, et al. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med. 2019;45:844\u201355.","journal-title":"Intensive Care Med"},{"key":"5212_CR11","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2023.09.037","author":"A Pruna","year":"2023","unstructured":"Pruna A, Bonaccorso A, Belletti A, Turi S, Di Prima AL, D\u2019amico F, et al. Methylene blue reduces mortality in critically ill and perioperative patients: a meta-analysis of randomized trials. J Cardiothorac Vasc Anesth. 2023. https:\/\/doi.org\/10.1053\/j.jvca.2023.09.037.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"5212_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419\u201330.","journal-title":"N Engl J Med"},{"key":"5212_CR13","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000006839","author":"M Sadjadi","year":"2024","unstructured":"Sadjadi M, von Groote T, Weiss R, Strau\u00df C, Wempe C, Albert F, et al. A pilot study of renin-guided angiotensin-ii infusion to reduce kidney stress after cardiac surgery. Anesth Analg. 2024. https:\/\/doi.org\/10.1213\/ANE.0000000000006839.","journal-title":"Anesth Analg"},{"key":"5212_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/anae.15802","volume":"77","author":"TG Coulson","year":"2022","unstructured":"Coulson TG, Miles LF, Serpa Neto A, Pilcher D, Weinberg L, Landoni G, et al. A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery*. Anaesthesia. 2022;77:999\u20131009.","journal-title":"Anaesthesia"},{"key":"5212_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"5212_CR16","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"5212_CR17","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"5212_CR18","unstructured":"McMaster University (developed by Evidence Prime). GRADEpro GDT 2015."},{"key":"5212_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13613-017-0243-z","volume":"7","author":"S Gaudry","year":"2017","unstructured":"Gaudry S, Messika J, Ricard J-D, Guillo S, Pasquet B, Dubief E, et al. Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review. Ann Intensive Care. 2017;7:28.","journal-title":"Ann Intensive Care"},{"key":"5212_CR20","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1164\/rccm.201401-0056CP","volume":"189","author":"MO Harhay","year":"2014","unstructured":"Harhay MO, Wagner J, Ratcliffe SJ, Bronheim RS, Gopal A, Green S, et al. Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med. 2014;189:1469\u201378.","journal-title":"Am J Respir Crit Care Med"},{"key":"5212_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13054-024-04967-3","volume":"28","author":"HGM Walker","year":"2024","unstructured":"Walker HGM, Brown AJ, Vaz IP, Reed R, Schofield MA, Shao J, et al. Composite outcome measures in high-impact critical care randomised controlled trials: a systematic review. Crit Care. 2024;28:184.","journal-title":"Crit Care"},{"key":"5212_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","volume":"27","author":"Y Kotani","year":"2023","unstructured":"Kotani Y, Di Gioia A, Landoni G, Belletti A, Khanna AK. An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity. Crit Care. 2023;27:29.","journal-title":"Crit Care"},{"key":"5212_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","volume":"61","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61:763\u20139.","journal-title":"J Clin Epidemiol"},{"key":"5212_CR24","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","volume":"33","author":"J Alban\u00e8se","year":"2005","unstructured":"Alban\u00e8se J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med. 2005;33:1897\u2013902.","journal-title":"Crit Care Med"},{"key":"5212_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/hep.30208","volume":"71","author":"V Arora","year":"2020","unstructured":"Arora V, Maiwall R, Rajan V, Jindal A, Muralikrishna Shasthry S, Kumar G, et al. Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure. Hepatology. 2020;71:600\u201310.","journal-title":"Hepatology"},{"key":"5212_CR26","first-page":"15","volume":"54","author":"E Barzegar","year":"2016","unstructured":"Barzegar E, Ahmadi A, Mousavi S, Nouri M, Mojtahedzadeh M. The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: microcirculation, is it the black box? Acta Med Iran. 2016;54:15\u201323.","journal-title":"Acta Med Iran"},{"key":"5212_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","volume":"18","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, et al. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care. 2014;18:534.","journal-title":"Crit Care"},{"key":"5212_CR28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/liv.13252","volume":"37","author":"A Choudhury","year":"2017","unstructured":"Choudhury A, Kedarisetty CK, Vashishtha C, Saini D, Kumar S, Maiwall R, et al. A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock. Liver Int. 2017;37:552\u201361.","journal-title":"Liver Int"},{"key":"5212_CR29","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","volume":"107","author":"MW D\u00fcnser","year":"2003","unstructured":"D\u00fcnser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313\u20139.","journal-title":"Circulation"},{"key":"5212_CR30","first-page":"114","volume":"13","author":"NJ Fonseca-Ruiz","year":"2013","unstructured":"Fonseca-Ruiz NJ, Cano ASL, Carmona DPO, Aguirre MC, G\u00f3mez Hern\u00e1ndez MP, Garc\u00eda CO, et al. Uso de vasopresina en pacientes con choque s\u00e9ptico refractario a catecolaminas. Acta Colomb Cuid Intensivo. 2013;13:114\u201323.","journal-title":"Acta Colomb Cuid Intensivo"},{"key":"5212_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509\u201318.","journal-title":"JAMA"},{"key":"5212_CR32","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/CCM.0000000000004023","volume":"47","author":"LA Hajjar","year":"2019","unstructured":"Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, et al. Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the VANCS II randomized clinical trial. Crit Care Med. 2019;47:1743\u201350.","journal-title":"Crit Care Med"},{"key":"5212_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jemermed.2012.02.073","volume":"44","author":"F Hua","year":"2013","unstructured":"Hua F, Wang X, Zhu L. Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock. J Emerg Med. 2013;44:434\u20139.","journal-title":"J Emerg Med"},{"key":"5212_CR34","first-page":"58","volume":"8","author":"RM Hussien","year":"2021","unstructured":"Hussien RM, El-Gendy HA, Elsaidy MI, Abdelhamid MS, Shabana TS. Comparison between norepinephrine alone versus norepinephrine\/vasopressin combination for resuscitation in septic shock: a randomized clinical trial. Egypt J Crit Care Med. 2021;8:58.","journal-title":"Egypt J Crit Care Med"},{"key":"5212_CR35","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","volume":"29","author":"MY Kirov","year":"2001","unstructured":"Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbj\u00f8rnsson B, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001;29:1860\u20137.","journal-title":"Crit Care Med"},{"key":"5212_CR36","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1001\/jama.2019.14607","volume":"322","author":"P-F Laterre","year":"2019","unstructured":"Laterre P-F, Berry SM, Blemings A, Carlsen JE, Fran\u00e7ois B, Graves T, et al. Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT Randomized clinical trial. JAMA. 2019;322:1476\u201385.","journal-title":"JAMA"},{"key":"5212_CR37","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","volume":"32","author":"F Lauzier","year":"2006","unstructured":"Lauzier F, L\u00e9vy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006;32:1782\u20139.","journal-title":"Intensive Care Med"},{"key":"5212_CR38","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","volume":"44","author":"ZM Liu","year":"2018","unstructured":"Liu ZM, Chen J, Kou Q, Lin Q, Huang X, Tang Z, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018;44:1816\u201325.","journal-title":"Intensive Care Med"},{"key":"5212_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","volume":"47","author":"MB Malay","year":"1999","unstructured":"Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47:699\u2013703.","journal-title":"J Trauma"},{"key":"5212_CR40","first-page":"868","volume":"99","author":"Y Lu","year":"2019","unstructured":"Lu Y, Yu H, Liu Q, Yao M, Zhu J. The therapeutic effect of continuous intravenous infusion of methylene blue on patients with septic shock. Natl Med J China. 2019;99:868\u201371.","journal-title":"Natl Med J China"},{"key":"5212_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/0310057X0203000606","volume":"30","author":"D Memis","year":"2002","unstructured":"Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care. 2002;30:755\u201362.","journal-title":"Anaesth Intensive Care"},{"key":"5212_CR42","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/bja\/aen017","volume":"100","author":"A Morelli","year":"2008","unstructured":"Morelli A, Ertmer C, Lange M, D\u00fcnser M, Rehberg S, Van Aken H, et al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth. 2008;100:494\u2013503.","journal-title":"Br J Anaesth"},{"key":"5212_CR43","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/cc7990","volume":"13","author":"A Morelli","year":"2009","unstructured":"Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13:R130.","journal-title":"Crit Care"},{"key":"5212_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","volume":"21","author":"JA Russell","year":"2017","unstructured":"Russell JA, Vincent J-L, Kj\u00f8lbye AL, Olsson H, Blemings A, Spapen H, et al. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care. 2017;21:213.","journal-title":"Crit Care"},{"key":"5212_CR45","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877\u201387.","journal-title":"N Engl J Med"},{"key":"5212_CR46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.5005\/jp-journals-10071-24231","volume":"26","author":"P Sahoo","year":"2022","unstructured":"Sahoo P, Kothari N, Goyal S, Sharma A, Bhatia PK. Comparison of norepinephrine and terlipressin vs norepinephrine alone for management of septic shock: a randomized control study. Indian J Crit Care Med. 2022;26:669\u201375.","journal-title":"Indian J Crit Care Med"},{"key":"5212_CR47","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4103\/0259-1162.206854","volume":"11","author":"M Senthilnathan","year":"2017","unstructured":"Senthilnathan M, Cherian A, Balachander H, Maroju NK. Role of methylene blue in the maintenance of postinduction hemodynamic status in patients with perforation peritonitis: a pilot study. Anesth Essays Res. 2017;11:665\u20139.","journal-title":"Anesth Essays Res"},{"key":"5212_CR48","first-page":"1043","volume":"59","author":"P Svoboda","year":"2012","unstructured":"Svoboda P, Scheer P, Kantorov\u00e1 I, Doubek J, Dudra J, Radvan M, et al. Terlipressin in the treatment of late phase catecholamine-resistant septic shock. Hepatogastroenterology. 2012;59:1043\u20137.","journal-title":"Hepatogastroenterology"},{"key":"5212_CR49","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/0886022X.2022.2095286","volume":"44","author":"J Wang","year":"2022","unstructured":"Wang J, Shi M, Huang L, Li Q, Meng S, Xu J, et al. Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study. Ren Fail. 2022;44:1207\u201315.","journal-title":"Ren Fail"},{"key":"5212_CR50","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jss.2015.07.016","volume":"200","author":"X Xiao","year":"2016","unstructured":"Xiao X, Zhang J, Wang Y, Zhou J, Zhu Y, Jiang D, et al. Effects of terlipressin on patients with sepsis via improving tissue blood flow. J Surg Res. 2016;200:274\u201382.","journal-title":"J Surg Res"},{"key":"5212_CR51","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S1388-9842(01)00155-6","volume":"3","author":"SR Bennett","year":"2001","unstructured":"Bennett SR, McKeown J, Drew P, Griffin S. Angiotensin in cardiac surgery: efficacy in patients on angiotensin converting enzyme inhibitors. Eur J Heart Fail. 2001;3:587\u201392.","journal-title":"Eur J Heart Fail"},{"key":"5212_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","volume":"126","author":"LA Hajjar","year":"2017","unstructured":"Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, Rhodes A, Landoni G, Osawa EA, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126:85\u201393.","journal-title":"Anesthesiology"},{"key":"5212_CR53","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","volume":"77","author":"RL Levin","year":"2004","unstructured":"Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77:496\u20139.","journal-title":"Ann Thorac Surg"},{"key":"5212_CR54","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/cc4845","volume":"10","author":"G Luckner","year":"2006","unstructured":"Luckner G, D\u00fcnser MW, Stadlbauer K-H, Mayr VD, Jochberger S, Wenzel V, et al. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care. 2006;10:R40.","journal-title":"Crit Care"},{"key":"5212_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","volume":"103","author":"AD Maslow","year":"2006","unstructured":"Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006;103:2\u20138.","journal-title":"Anesth Analg"},{"key":"5212_CR56","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0003-4975(02)04408-9","volume":"75","author":"DLS Morales","year":"2003","unstructured":"Morales DLS, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75:926\u201330.","journal-title":"Ann Thorac Surg"},{"key":"5212_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.jvca.2014.07.007","volume":"29","author":"Y Okamoto","year":"2015","unstructured":"Okamoto Y, Nohmi T, Higa Y, Seki K, Yamashita A. Vasopressin does not raise cardiac enzymes following cardiac surgery: a randomized double-blind clinical trial. J Cardiothorac Vasc Anesth. 2015;29:46\u201351.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"5212_CR58","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","volume":"79","author":"E Ozal","year":"2005","unstructured":"Ozal E, Kuralay E, Yildirim V, Kilic S, Bolcal C, K\u00fcc\u00fckarslan N, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79:1615\u20139.","journal-title":"Ann Thorac Surg"},{"key":"5212_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1749-8090-5-17","volume":"5","author":"G Papadopoulos","year":"2010","unstructured":"Papadopoulos G, Sintou E, Siminelakis S, Koletsis E, Baikoussis NG, Apostolakis E. Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting\u2013a double-blind randomized study. J Cardiothorac Surg. 2010;5:17.","journal-title":"J Cardiothorac Surg"},{"key":"5212_CR60","doi-asserted-by":"publisher","first-page":"110108","DOI":"10.1016\/j.jclinane.2020.110108","volume":"68","author":"Y Deng","year":"2021","unstructured":"Deng Y, Wang R, Li S, Zhu X, Wang T, Wu J, et al. Methylene blue reduces incidence of early postoperative cognitive disorders in elderly patients undergoing major non-cardiac surgery: an open-label randomized controlled clinical trial. J Clin Anesth. 2021;68:110108.","journal-title":"J Clin Anesth"},{"key":"5212_CR61","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4103\/aer.AER_30_19","volume":"13","author":"AS Elgebaly","year":"2019","unstructured":"Elgebaly AS, Abd El Ghafar MS, Fathy SM, Shaddad MN. Vasopressin continuous infusion improves intracranial pressure and patient outcomes after surgical clipping or endovascular coiling of cerebral aneurysm. Anesth Essays Res. 2019;13:528\u201334.","journal-title":"Anesth Essays Res"},{"key":"5212_CR62","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/147323001204000123","volume":"40","author":"SH Hong","year":"2012","unstructured":"Hong SH, Lee JM, Choi JH, Chung HS, Park JH, Park CS. Perioperative assessment of terlipressin infusion during living donor liver transplantation. J Int Med Res. 2012;40:225\u201336.","journal-title":"J Int Med Res"},{"key":"5212_CR63","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s11605-022-05499-3","volume":"27","author":"J Huang","year":"2023","unstructured":"Huang J, Gao X, Wang M, Yang Z, Xiang L, Li Y, et al. Prophylactic administration with methylene blue improves hemodynamic stabilization during obstructive jaundice-related diseases\u2019 operation: a blinded randomized controlled trial. J Gastrointest Surg. 2023;27:1837\u201345.","journal-title":"J Gastrointest Surg"},{"key":"5212_CR64","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/00000539-200204000-00009","volume":"94","author":"H Koelzow","year":"2002","unstructured":"Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg. 2002;94:824\u20139.","journal-title":"Anesth Analg"},{"key":"5212_CR65","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.hpb.2019.10.011","volume":"22","author":"A Kohler","year":"2020","unstructured":"Kohler A, Perrodin S, De Gottardi A, Candinas D, Beldi G. Effectiveness of terlipressin for prevention of complications after major liver resection\u2013a randomized placebo-controlled trial. HPB. 2020;22:884\u201391.","journal-title":"HPB"},{"key":"5212_CR66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12871-019-0779-6","volume":"19","author":"MM Mahdy","year":"2019","unstructured":"Mahdy MM, Abbas MS, Kamel EZ, Mostafa MF, Herdan R, Hassan SA, et al. Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial. BMC Anesthesiol. 2019;19:106.","journal-title":"BMC Anesthesiol"},{"key":"5212_CR67","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/lt.24759","volume":"23","author":"MS Reddy","year":"2017","unstructured":"Reddy MS, Kaliamoorthy I, Rajakumar A, Malleeshwaran S, Appuswamy E, Lakshmi S, et al. Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation. Liver Transpl. 2017;23:1007\u201314.","journal-title":"Liver Transpl"},{"key":"5212_CR68","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejogrb.2015.10.003","volume":"195","author":"T Song","year":"2015","unstructured":"Song T, Kim MK, Kim M-L, Jung YW, Yun BS, Seong SJ. Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015;195:177\u201381.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5212_CR69","first-page":"1923","volume":"109","author":"L Zhang","year":"2023","unstructured":"Zhang L, Tian M, Sun L-Y, Zhu Z-J. Prophylactic terlipressin infusion for severe postreperfusion syndrome in patients undergoing deceased donor liver transplantation: the TIPS-DDLT randomized controlled trial. Int J Surg. 2023;109:1923\u201331.","journal-title":"Int J Surg"},{"key":"5212_CR70","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.jvca.2009.08.001","volume":"24","author":"S Hasija","year":"2010","unstructured":"Hasija S, Makhija N, Choudhury M, Hote M, Chauhan S, Kiran U. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010;24:230\u20138.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"5212_CR71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-019-2362-4","volume":"23","author":"L Jiang","year":"2019","unstructured":"Jiang L, Sheng Y, Feng X, Wu J. The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis. Crit Care. 2019;23:91.","journal-title":"Crit Care"},{"key":"5212_CR72","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1053\/j.jvca.2018.04.006","volume":"32","author":"MW D\u00fcnser","year":"2018","unstructured":"D\u00fcnser MW, Bouvet O, Knotzer H, Arulkumaran N, Hajjar LA, Ulmer H, et al. Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2018;32:2225\u201332.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"5212_CR73","first-page":"1577","volume":"38","author":"K Heybati","year":"2024","unstructured":"Heybati K, Xie G, Ellythy L, Poudel K, Deng J, Zhou F, et al. Outcomes of vasopressin-receptor agonists versus norepinephrine in adults with perioperative hypotension: a systematic review. J Cardiothorac Vasc Anesth. 2024;38:1577\u201386.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"5212_CR74","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40560-020-00500-0","volume":"8","author":"L Zhong","year":"2020","unstructured":"Zhong L, Ji X-W, Wang H-L, Zhao G-M, Zhou Q, Xie B. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials. J Intensive Care. 2020;8:83.","journal-title":"J Intensive Care"},{"key":"5212_CR75","doi-asserted-by":"publisher","first-page":"e1110","DOI":"10.1097\/CCE.0000000000001110","volume":"6","author":"SM Fernando","year":"2024","unstructured":"Fernando SM, Tran A, Soliman K, Flynn B, Oommen T, Wenzhe L, et al. Methylene blue in septic shock: a systematic review and meta-analysis. Crit Care Explor. 2024;6:e1110.","journal-title":"Crit Care Explor"},{"key":"5212_CR76","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00134-017-4832-y","volume":"43","author":"M Joannidis","year":"2017","unstructured":"Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the working group on prevention, AKI section, European society of intensive care medicine. Intensive Care Med. 2017;43:730\u201349.","journal-title":"Intensive Care Med"},{"key":"5212_CR77","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","volume":"46","author":"JA Tumlin","year":"2018","unstructured":"Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, et al. Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med. 2018;46:949\u201357.","journal-title":"Crit Care Med"},{"key":"5212_CR78","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395:200\u201311.","journal-title":"Lancet"},{"key":"5212_CR79","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","volume":"210","author":"AC Gordon","year":"2024","unstructured":"Gordon AC, Alipanah-Lechner N, Bos LD, Dianti J, Diaz JV, Finfer S, et al. From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU. Am J Respir Crit Care Med. 2024;210:155\u201366.","journal-title":"Am J Respir Crit Care Med"},{"key":"5212_CR80","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","volume":"202","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW, et al. Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Respir Crit Care Med. 2020;202:1253\u201361.","journal-title":"Am J Respir Crit Care Med"},{"key":"5212_CR81","doi-asserted-by":"publisher","first-page":"e737","DOI":"10.1097\/CCM.0000000000001631","volume":"44","author":"D Roth","year":"2016","unstructured":"Roth D, Heidinger B, Havel C, Herkner H. Different mortality time points in critical care trials: current practice and influence on effect estimates in meta-analyses. Crit Care Med. 2016;44:e737\u201341.","journal-title":"Crit Care Med"},{"key":"5212_CR82","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","volume":"52","author":"PM Wieruszewski","year":"2024","unstructured":"Wieruszewski PM, Leone M, Kaas-Hansen BS, Dugar S, Legrand M, McKenzie CA, et al. Position paper on the reporting of norepinephrine formulations in critical care from the society of critical care medicine and European society of intensive care medicine joint task force. Crit Care Med. 2024;52:521\u201330.","journal-title":"Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-05212-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T14:03:57Z","timestamp":1735567437000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-05212-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5212"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-05212-7","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YK has received consultancy fees from Viatris. PMW previously received consultant fees from Viatris. AKK received consulting fees from Medtronic, Edwards Life Sciences, Philips Research North America, Hillrom, GE Healthcare, Potrero Medical, Viatris Pharma, Trevena Pharma, Fifth Eye Inc., Pharmazz Inc., Retia Medical and Caretaker Medical. He is also funded with a Wake Forest Clinical and Translational Science Institute (CTSI) grant on renin dysfunction in septic shock. GL has received speaker fees from Medis, Paion, and Viatris and consultancy fees from Paion and Viatris. RB has received grants and consultancy fees from La Jolla Pharmaceuticals, Paion AG, and Viatris. The other authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}